Compass Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Compass Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$325K	Buy	+5,648	New	+$324K	0.06%	147
2025 Q4	–	Sell	-5,237	Closed	-$236K	–	85
2025 Q3	$236K	Buy	+5,237	New	+$245K	0.05%	141
2025 Q2	–	Sell	-3,698	Closed	-$226K	–	183
2025 Q1	$226K	Buy	3,698 +1,500	+68%	+$87.4K	0.06%	144
2024 Q4	$124K	Hold	2,198	–	–	0.03%	180
2024 Q3	$114K	Sell	2,198 -3,632	-62%	-$170K	0.03%	191
2024 Q2	$242K	Sell	5,830 -1,832	-24%	-$82K	0.06%	149
2024 Q1	$416K	Sell	7,662 -5,460	-42%	-$278K	0.1%	120
2023 Q4	$673K	Sell	13,122 -10,931	-45%	-$574K	0.19%	100
2023 Q3	$1.4M	Sell	24,053 -467	-2%	-$28.6K	0.44%	72
2023 Q2	$1.57M	Sell	24,520 -500	-2%	-$33.5K	0.47%	67
2023 Q1	$1.73M	Sell	25,020 -914	-4%	-$64.5K	0.55%	63
2022 Q4	$1.87M	Buy	+25,934	New	+$1.96M	0.61%	58

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Compass Wealth Management's BMY Position: Q2 2026 in Review

Compass Wealth Management opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 5,648 shares worth $325K. The stake represents 0.06% of the portfolio and ranks #147 among its holdings. This is a return to the name: Compass Wealth Management previously reported a position in BMY as recently as Q3 2025.

Compass Wealth Management first reported a position in BMY in Q4 2022 and has held it in 12 quarters since. The position peaked at $1.87M in Q4 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Compass Wealth Management held 5,648 shares of Bristol-Myers Squibb worth $325K as of Q2 2026.
Bristol-Myers Squibb was a new Compass Wealth Management position in Q2 2026.
Bristol-Myers Squibb made up 0.06% of Compass Wealth Management's portfolio in Q2 2026, its #147 holding.
Compass Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 12 quarters since.
Compass Wealth Management's Bristol-Myers Squibb position peaked at $1.87M in Q4 2022.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Compass Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.